Detalhe da pesquisa
1.
Outcome and feasibility of radiotherapy bridging in large B-cell lymphoma patients receiving CD19 CAR T in the UK.
Br J Haematol
; 2024 Apr 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-38594876
2.
The ECHELON-2 Trial: 5-year results of a randomized, phase III study of brentuximab vedotin with chemotherapy for CD30-positive peripheral T-cell lymphoma.
Ann Oncol
; 33(3): 288-298, 2022 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-34921960
3.
Radiotherapy and anti-PD-1/PD-L1 combinations in lung cancer: building better translational research platforms.
Ann Oncol
; 29(2): 301-310, 2018 02 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29309540
4.
Final results of a multicenter phase II study of the purine nucleoside phosphorylase (PNP) inhibitor forodesine in patients with advanced cutaneous T-cell lymphomas (CTCL) (Mycosis fungoides and Sézary syndrome).
Ann Oncol
; 25(9): 1807-1812, 2014 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-24948692
5.
British Association of Dermatologists and U.K. Cutaneous Lymphoma Group guidelines for the management of primary cutaneous lymphomas 2018.
Br J Dermatol
; 180(3): 496-526, 2019 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-30561020
6.
Phase II study of gemcitabine and bexarotene (GEMBEX) in the treatment of cutaneous T-cell lymphoma.
Br J Cancer
; 109(10): 2566-73, 2013 Nov 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-24136145
7.
A study to investigate dose escalation of doxorubicin in ABVD chemotherapy for Hodgkin lymphoma incorporating biomarkers of response and toxicity.
Br J Cancer
; 109(10): 2560-5, 2013 Nov 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-24136151
8.
Breast cancer risk following Hodgkin lymphoma radiotherapy in relation to menstrual and reproductive factors.
Br J Cancer
; 108(11): 2399-406, 2013 Jun 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-23652303
9.
Recommendations for the clinical management of the elderly patient with malignant lymphoma.
Ann Oncol
; 29(4): 1069-1070, 2018 04 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29360921
10.
Hodgkin lymphoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.
Ann Oncol
; 29(Suppl 4): iv19-iv29, 2018 10 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29796651
11.
U.K. consensus statement on safe clinical prescribing of bexarotene for patients with cutaneous T-cell lymphoma.
Br J Dermatol
; 168(1): 192-200, 2013 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-22963233
12.
Assessment of circulating biomarkers for potential pharmacodynamic utility in patients with lymphoma.
Br J Cancer
; 104(4): 719-25, 2011 Feb 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-21245866
13.
Extranodal diffuse large B-cell lymphoma (DLBCL) and primary mediastinal B-cell lymphoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.
Ann Oncol
; 27(suppl 5): v91-v102, 2016 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-27377716
14.
A retrospective analysis of selective internal radiation therapy (SIRT) with yttrium-90 microspheres in patients with unresectable hepatic malignancies.
Clin Radiol
; 65(9): 720-8, 2010 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-20696299
15.
Hodgkin's lymphoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.
Ann Oncol
; 25 Suppl 3: iii70-5, 2014 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-25185243
16.
The Radiotherapy Learning Healthcare System - Working Together to Improve the Quality of Radiotherapy Nationally.
Clin Oncol (R Coll Radiol)
; 34(6): 411-414, 2022 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-35120791
17.
A TLR7 agonist enhances the antitumor efficacy of obinutuzumab in murine lymphoma models via NK cells and CD4 T cells.
Leukemia
; 31(10): 2278, 2017 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-28751765
18.
A TLR7 agonist enhances the antitumor efficacy of obinutuzumab in murine lymphoma models via NK cells and CD4 T cells.
Leukemia
; 31(7): 1611-1621, 2017 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-27890931
19.
Immune Checkpoint Inhibitors in Lung Cancer - An Unheralded Opportunity?
Clin Oncol (R Coll Radiol)
; 29(4): 207-217, 2017 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-28063623
20.
Guidelines for preclinical and early phase clinical assessment of novel radiosensitisers.
Br J Cancer
; 105(5): 628-39, 2011 Aug 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-21772330